# Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema

> **NCT06155513** · NA · TERMINATED · sponsor: **SCF Pharma** · enrollment: 7 (actual)

## Conditions studied

- Eczema

## Interventions

- **COMBINATION_PRODUCT:** Omega-3 monoglyceride based topical Serum and cream of formulation A (light)
- **COMBINATION_PRODUCT:** Omega-3 monoglyceride based topical Serum and cream of formulation B (rich)

## Key facts

- **NCT ID:** NCT06155513
- **Lead sponsor:** SCF Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-12-20
- **Primary completion:** 2025-11-05
- **Final completion:** 2025-11-05
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** There has been an important change to the product formulation.
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06155513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06155513, "Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06155513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*